ClinicalTrials.Veeva

Menu

rTMS Study to Improve Functional Performance for Patients With Stroke

T

Taipei Medical University

Status and phase

Completed
Phase 3

Conditions

Stroke

Treatments

Device: rTMS

Study type

Interventional

Funder types

Other

Identifiers

NCT02006875
102-wf-eva-04

Details and patient eligibility

About

To use repetitive transcranial magnetic stimulation (rTMS) to treat stroke patients is getting a popular idea. Previous studies seemed to support its effects on facilitating motor recovery after stroke. This study focuses on the motor recovery of lower extremities. Investigators conducted the study to evaluate the treatment effect of rTMS on the functional performance of lower extremities in terms of postural control, balance, and mobility in stroke patients. Investigators hypothesized that these performances could be improved through the better motor control of lower extremities caused by rTMS.

Full description

Protocol:

  1. Setting: inpatient rehabilitation department of Shuang-Ho Hospital.

  2. Study population: Patients received inpatient treatment or rehabilitation for stroke in Shuang-Ho Hospital (SHH).

  3. Eligibility. Screening for eligibility was done by the 2 physiatrists from rehabilitation department of SHH.

  4. Study design: controlled trial with stratified randomization

  5. Blinding

    1. The patients were blinded by the real or sham coil of rTMS
    2. The assessors who performed the outcome measurements were blinded to the assignment of treatment.
  6. Measurements.

    1. Baseline demographic records. The stroke severity was measured by National Institutes of Health Stroke Scale (NIHSS), Modified Rankin Scale (MRS), Brunnstrum stage, and Manual muscle test (MMT) before intervention.

    2. Clinical assessments.

      • Postural control was assessed by Postural Assessment Scale for Stroke Patients (PASS)
      • The motor recovery of lower extremities was assessed by the lower extremity subscale of Fugl-Meyer Assessment (FMA-LE)
      • The balance and gait subscales of Tinetti Performance Oriented Mobility Assessment (POMA-b and POMA-g)
      • Timed Up and Go (TUG) test was used to assess the gross mobility.
      • Barthel Index (BI) for the ADL independence
      • modified Rankin Scale (MRS) for disability classification were also collected.
    3. These measurements (including the clinical and corticomotor excitability assessments) are performed by one researcher who are responsible for the measurements.

  7. Compliance and side effect. The compliance of interventions were investigated. The attendance of treatments (including rTMS sessions and physical therapy sessions) and possible side effect/discomfort were recorded during the interventions by a researcher. He also tries to understand the reason of drop-out from the study.

Enrollment

60 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • unilateral hemiplegia caused by the stroke,
  • first ever stroke,
  • time since stroke: 10-90 days,
  • age: 18-80 y/o,
  • Functional ambulation classification (FAC): 0-2,

Exclusion criteria

  • contraindication to TMS (eg, pacemaker, seizure history, pregnancy),
  • cranial metal implants
  • intracranial hemorrhage associated with tumor or arteriovenous malformation, craniotomy
  • able to complete Timed Up and Go (TUG) test within 2 minutes
  • unable to walk normally before the stroke
  • those whose motor evoked potentials (MEP) of M1-UH were absent in the pretest

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Triple Blind

60 participants in 2 patient groups

real rTMS
Experimental group
Description:
Experimental included the a daily real rTMS session for 15 mins followed by a physical therapy for 45 mins.
Treatment:
Device: rTMS
sham rTMS
Sham Comparator group
Description:
the control interventions included a daily sham rTMS session for 15 minutes followed by a physical therapy for 45 minutes.
Treatment:
Device: rTMS

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems